New ultrasound technique aims to better measure liver health
NCT ID NCT01082419
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new ultrasound technique called ARFI to measure liver stiffness in 109 people, including healthy volunteers and patients with liver conditions. The goal was to understand normal stiffness values and how they change with disease or treatment. This is an observational study, not a treatment trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
109 people
The number who actually took part.
- Start date
-
Apr 2010
- Finished
-
Apr 2013
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Man or Woman * Age\> 18 years old * Able to understand the study and to give informed consent * Informed consent signed by patient and investigator before any study required examination * With a valid health insurance * Groups specific inclusion criteria are: * Group A : healthy volunteers without known liver disease * Group B : voluntary patients without known liver disease * Group C and D Patient with a diagnosed chronic liver disease * Group E : patients with liver tumors (benign or malignant) with surgical indication * Group F : patients with acute right heart insufficiency diagnosed by a cardiologist * Group G :patients with biliary cholestasis and imaging evidence of biliary dilatation Exclusion Criteria: * Patient under 18 years old * Not able to understand the study or to give their consent. * Pregnant woman * Severe respiratory insufficiency * Unable to perform a "light" apnea . * hemodynamic instability (cardiogenic shock, septic or anaphylactic) possibility of disruption of the elasticity and inability to carry patient. * Chronic heart insufficiency. * deprived of their liberty by court
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute right heart insufficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Bordeaux
Bordeaux, 33075, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Underactive thyroid may worsen liver scarring in fatty liver disease
- Gut bacteria in a capsule: a new attempt to calm a brain complication of cirrhosis
- Sound waves may replace the needle in liver scarring tests
- Can a new ultrasound device spot liver damage without a biopsy?
- Can a digital platform catch liver cancer sooner?
- Can a Two-Drug combo keep cirrhosis patients out of the hospital?